May 15, 2025
The US Food and Drug Administration (FDA) has approved belzutifan (Welireg, Merck) for adult and pediatric patients aged 12 years or older with locally advanced, unresectable, […]
May 15, 2025
TOPLINE: Adding radium-223 dichloride (Ra223) to metastasis-directed stereotactic ablative radiotherapy (SABR) did not improve progression-free survival compared with SABR alone in men with bone-only oligometastatic castration-sensitive […]
May 15, 2025
TOPLINE: Remote symptom monitoring (RSM) using electronic patient-reported outcomes reduced hospitalizations by 19% at 3 months and 13% at 6 months in patients with cancer receiving […]
May 14, 2025
TOPLINE: In a multicenter cohort study of 575 South Korean patients with BRCA1 or BRCA2 pathogenic variants, breast-conserving treatment demonstrated comparable oncologic outcomes to mastectomy over […]
May 14, 2025
The trends are clear: Americans are in the midst of a marijuana high. Over the past 30 years, daily or near-daily marijuana use soared 15-fold, surpassing […]
May 14, 2025
TOPLINE: In patients with recurrent non–small cell lung cancer (NSCLC), salvage thoracic reirradiation prolonged overall survival and progression-free survival. Consolidative immunotherapy following reirradiation further improved overall […]
May 14, 2025
In oncology, positive outcomes from industry-sponsored clinical trials on solid tumors are frequently first announced via press releases (PRs) — often with limited detail — well […]
May 14, 2025
The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous […]
May 12, 2025
TOPLINE: In patients with early-stage oral cavity carcinoma and a low risk for regional recurrence, omitting elective neck irradiation during postoperative radiotherapy was associated with low […]